156 related articles for article (PubMed ID: 36849229)
21. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
Li T; Ning X; He Q; Gong K
Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
[TBL] [Abstract][Full Text] [Related]
22. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract][Full Text] [Related]
23. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
[TBL] [Abstract][Full Text] [Related]
24. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
[TBL] [Abstract][Full Text] [Related]
25. Birt-Hogg-Dubé syndrome in Korean: clinicoradiologic features and long term follow-up.
Lee JH; Jeon MJ; Song JS; Chae EJ; Choi JH; Kim GH; Song JW
Korean J Intern Med; 2019 Jul; 34(4):830-840. PubMed ID: 30360018
[TBL] [Abstract][Full Text] [Related]
26. PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis.
van de Beek I; Glykofridis IE; Oosterwijk JC; van den Akker PC; Diercks GFH; Bolling MC; Waisfisz Q; Mensenkamp AR; Balk JA; Zwart R; Postma AV; Meijers-Heijboer HEJ; van Moorselaar RJA; Wolthuis RMF; Houweling AC
Hum Mol Genet; 2023 Mar; 32(7):1223-1235. PubMed ID: 36440963
[TBL] [Abstract][Full Text] [Related]
27. Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation.
Hao S; Long F; Sun F; Liu T; Li D; Jiang S
BMC Pulm Med; 2017 Feb; 17(1):43. PubMed ID: 28222720
[TBL] [Abstract][Full Text] [Related]
28. Genotypic characteristics of Chinese patients with BHD syndrome and functional analysis of FLCN variants.
Liu K; Xu W; Tian X; Xiao M; Zhao X; Zhang Q; Qu T; Song J; Liu Y; Xu KF; Zhang X
Orphanet J Rare Dis; 2019 Oct; 14(1):223. PubMed ID: 31615547
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
[TBL] [Abstract][Full Text] [Related]
30. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
Wu J; Lu J; Wu CL; Lu M
Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
[TBL] [Abstract][Full Text] [Related]
31. Birt-Hogg-Dube syndrome: clinicopathological features of the lung.
Furuya M; Nakatani Y
J Clin Pathol; 2013 Mar; 66(3):178-86. PubMed ID: 23223565
[TBL] [Abstract][Full Text] [Related]
32. Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts.
Iwabuchi C; Ebana H; Ishiko A; Negishi A; Mizobuchi T; Kumasaka T; Kurihara M; Seyama K
J Dermatol Sci; 2018 Jan; 89(1):77-84. PubMed ID: 29157599
[TBL] [Abstract][Full Text] [Related]
33. Clinical and genetic characteristics of chinese patients with Birt-Hogg-Dubé syndrome.
Liu Y; Xu Z; Feng R; Zhan Y; Wang J; Li G; Li X; Zhang W; Hu X; Tian X; Xu KF; Zhang X
Orphanet J Rare Dis; 2017 May; 12(1):104. PubMed ID: 28558743
[TBL] [Abstract][Full Text] [Related]
34. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
35. Delayed diagnosis of Birt-Hogg-Dubé syndrome due to marked intrafamilial clinical variability: a case report.
Sattler EC; Steinlein OK
BMC Med Genet; 2018 Mar; 19(1):45. PubMed ID: 29548312
[TBL] [Abstract][Full Text] [Related]
36. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
[TBL] [Abstract][Full Text] [Related]
37. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
38. [Two families with Birt-Hogg-Dubé syndrome:case report and literature review].
Zhan DT; Chen RC; Wang LW
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jan; 45(1):59-63. PubMed ID: 35000307
[No Abstract] [Full Text] [Related]
39. Birt-Hogg-Dubé syndrome in two Chinese families with mutations in the FLCN gene.
Hou X; Zhou Y; Peng Y; Qiu R; Xia K; Tang B; Zhuang W; Jiang H
BMC Med Genet; 2018 Jan; 19(1):14. PubMed ID: 29357828
[TBL] [Abstract][Full Text] [Related]
40. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
